Insider · CIK 0001612627
Kristiina Vuori MD
Files at BNGO (Bionano Genomics, Inc.), FORA (Forian Inc.), INBX (Inhibrx Biosciences, Inc.). First filing -, latest -.
Kristiina Vuori MD files SEC Form 4 as director at BNGO (Bionano Genomics, Inc.), and also at FORA (Forian Inc.), INBX (Inhibrx Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kristiina Vuori MD has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | 25 d ago |
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 4, 2026 |
| May 15, 2026 | FORA Forian Inc. | UTender of shares Common Stock | -28,757 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | FORA Forian Inc. | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 14, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +9,149 | $0.00 | $0 | 9,149 | May 14, 2026 |
| Jun 11, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,775 | $0.00 | $0 | 2,775 | Jun 12, 2025 |
| May 28, 2025 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | May 29, 2025 |
| Mar 26, 2025 | FORA Forian Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Mar 28, 2025 |
Questions about Kristiina Vuori MD
Answered from the filings on this page, as of the latest one.
Is Kristiina Vuori MD buying or selling?
Kristiina Vuori MD has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kristiina Vuori MD's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kristiina Vuori MD has 0.
Where does Kristiina Vuori MD file Form 4?
Kristiina Vuori MD has filed Form 4 at BNGO (Bionano Genomics, Inc.); FORA (Forian Inc.); INBX (Inhibrx Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.